Natus Medical Incorporated (BABY) is Trading Lower on Unusual Volume for January 11

Equities Staff |

Natus Medical Incorporated (BABY) experienced unusually high volume on Jan. 11, as the stock lost 12.04% to a closing price of $38.00. The stock saw 1.23 million shares trade hands over the course of the day on 9,105 trades. Given that the stock’s average daily volume over the last month has been 290,144 shares a day, this represents a pretty substantial spike over the norm.

Natus Medical Incorporated has a P/B ratio of 3.3. It also has a P/E ratio of 36.3. The stock has traded between $51.05 and $29.34 over the last 52-weeks, its 50-day SMA is now $47.89, and its 200-day SMA $42.87.

Natus Medical Inc provides newborn care & neurology healthcare products & services used for screening, diagnosis, detection, treatment, monitoring & tracking of medical ailments in newborn care, epilepsy, sleep disorders, and balance & mobility disorders.

Headquartered in Pleasanton, CA, Natus Medical Incorporated has 948 employees and is currently under the leadership of CEO James B. Hawkins.

For a complete fundamental analysis analysis of Natus Medical Incorporated, check out’s Stock Valuation Analysis report for BABY. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Blow & Drive Interlock Corp

Blow & Drive Interlock Corp manufactures, markets, leases, installs and monitors a Breath Alcohol Ignition Interlock Device mechanism on the steering column of an automobile and into which a driver…

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…